Crohn’s disease (CD) is a chronic, progressive inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal (GI) tract—from the mouth to the anus. It most commonly affects the ...

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis ...

Agomab’s ALK5 inhibitor has proven its ability to target the correct part of the intestine in a phase 2 trial of fibrostenosing Crohn’s disease. The STENOVA study saw 90 patients with the ...

ALBUQUERQUE, N.M. — Crohn's disease is a serious long-term condition affecting hundreds of thousands of people in this country and gets a lot of attention at the University of New Mexico Hospital.